Switch to:

Arrowhead Pharmaceuticals Equity-to-Asset

: 0.89 (As of Jun. 2020)
View and export this data going back to 1997. Start your Free Trial

Equity to Asset ratio is calculated as shareholder's tangible equity divided by its total asset. Arrowhead Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Jun. 2020 was $493.1 Mil. Arrowhead Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2020 was $555.7 Mil. Therefore, Arrowhead Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Jun. 2020 was 0.89.

NAS:ARWR' s Equity-to-Asset Range Over the Past 10 Years
Min: -39.56   Med: 0.77   Max: 0.95
Current: 0.89

-39.56
0.95

During the past 13 years, the highest Equity to Asset Ratio of Arrowhead Pharmaceuticals was 0.95. The lowest was -39.56. And the median was 0.77.

NAS:ARWR's Equity-to-Asset is ranked higher than
88% of the 804 Companies
in the Biotechnology industry.

( Industry Median: 0.66 vs. NAS:ARWR: 0.89 )

Arrowhead Pharmaceuticals Equity-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.75 0.78 0.86 0.70

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.70 0.85 0.88 0.89

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arrowhead Pharmaceuticals Equity-to-Asset Distribution

* The bar in red indicates where Arrowhead Pharmaceuticals's Equity-to-Asset falls into.



Arrowhead Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing shareholder's tangible equity divided by its total asset.

Arrowhead Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Sep. 2019 is calculated as

Equity to Asset (A: Sep. 2019 )=Total Stockholders Equity/Total Assets
=244.591/349.845
=0.70

Arrowhead Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Jun. 2020 is calculated as

Equity to Asset (Q: Jun. 2020 )=Total Stockholders Equity/Total Assets
=493.14/555.728
=0.89

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals  (NAS:ARWR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Arrowhead Pharmaceuticals Equity-to-Asset Related Terms


Arrowhead Pharmaceuticals Equity-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)